{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-014642","form_type":"8-K","ticker":"CHRS","cik":"0001512762","company_name":"Coherus Oncology, Inc.","filed_at":"2024-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.644335+00:00","generated_at":"2026-05-30T04:28:41.466297+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Coherus Q3 revenue $70.8M, UDENYCA up 30% QoQ; net loss narrows to $10.8M from $39.6M YoY","bullets":["Net revenue $70.8M; UDENYCA $66.1M (+30% QoQ, +100% YoY); LOQTORZI $5.8M (+54% QoQ).","Net loss $10.8M ($0.09 loss per share) vs $39.6M loss in Q3 2023; non-GAAP net loss $1.7M.","UDENYCA supply: CMO resumes production; backlog ~120k units expected by year-end; new CMO testing, commercial supply Q1 2025.","Pipeline: Phase 2 HCC study of casdozokitug+toripalimab+bevacizumab opening; CHS-114 Phase 1 data expected H1 2025.","Gross profit improved on divested products (CIMERLI, YUSIMRY); SG&A down $13.5M YoY on lower headcount."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-014642","json":"https://secwatch.observer/filing/0001558370-24-014642.json","markdown":"https://secwatch.observer/filing/0001558370-24-014642.md","text":"https://secwatch.observer/filing/0001558370-24-014642.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1512762/000155837024014642/0001558370-24-014642-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1512762/000155837024014642/chrs-20241106x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T04:28:41.466297+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}